Natural History Study in Patients With LGMDR5/2c

NCT06210672 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-10-06

No results posted yet for this study

Summary

Prospective, longitudinal, interventional, multicenter natural history study to better understand the LGMDR5/2c disease physiopathology. The duration of participation for each patient will be up to 24 months.

Conditions

  • Gamma-sarcoglycanopathy

Sponsors & Collaborators

  • Atamyo Therapeutics

    lead INDUSTRY

Eligibility

Min Age
6 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • France
  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06210672 on ClinicalTrials.gov